Reference SummaryUmeda Y, J Occup Health 2004 Mar;46(2):87-99
Title |
Carcinogenicity and chronic toxicity in mice and rats administered vinyl acetate monomer in drinking water. |
Authors |
Umeda Y; Matsumoto M; Yamazaki K; Ohnishi M; Arito H; Nagano K; Yamamoto S; Matsushima T |
Journal |
J Occup Health |
Volume |
46 |
Issue |
2 |
Year |
2004 |
Pages |
87-99 |
Abstract |
Carcinogenicity and chronic toxicity of vinyl acetate monomer (VA) were examined in male and female Crj:BDF1 mice and F344/DuCrj Rats. Groups of 50 mice and 50 rats of each sex were orally administered VA in drinking water containing 0, 400, 2,000 or 10,000 ppm (g/g) VA for 104 wk. Squamous cell tumors were clearly evident in the upper digestive tract of treated mice and rats, and in the larynx of treated mice of both sexes. In mice, squamous cell carcinomas and papillomas were observed in the oral cavity, esophagus, forestomach and larynx of the 10,000 ppm group, together with basal cell hyperplasia, squamous cell hyperplasia and epithelial dysplasia. In rats, incidences of squamous cell carcinomas and papillomas were increased in the oral cavity of the 10,000 ppm group of both sexes, and an esophagus squamous cell carcinoma was observed in a 10,000 ppm female. Pre-neoplastic hyperplasias were also noted. Mapping of the neoplastic and pre-neoplastic lesions in the oral cavity of the 10,000 ppm group revealed that both the lesions occurred predominantly at Level V in mice and at Level VI in rats. A lower confidence limit of a benchmark dose (BMDL10) of 477 mg/kg/d was obtained from a dose-response relationship between combined incidence of squamous cell carcinomas and papillomas in the oral cavity of mice and rats and the estimated daily VA intakes per body weight, and compared with literature values. |
Links |
J:90187 – MGI References 15090683 – National Library of Medicine/PubMed |
Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
---|---|---|---|---|---|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Blood vessel hemangiosarcoma | Liver |
6 - 8 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Blood vessel hemangiosarcoma | Spleen |
2 - 4 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Blood vessel hemangiosarcoma |
|
Liver |
0 - 10 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Blood vessel hemangiosarcoma |
|
Spleen |
0 - 8 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Bone - Jaw - Mandible dysplasia - epithelial |
|
Bone - Jaw - Mandible |
8.57 - 44.19 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Bone - Jaw - Mandible hyperplasia - basal cell |
|
Bone - Jaw - Mandible |
0 - 41.86 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Bone - Jaw - Mandible hyperplasia - squamous |
|
Bone - Jaw - Mandible |
8.57 - 23.26 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Bone - Jaw - Mandible lesion |
|
Bone - Jaw - Mandible |
6 - 10 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Bone - Jaw - Mandible squamous cell carcinoma |
|
Bone - Jaw - Mandible |
0 - 31.43 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Bone - Jaw - Mandible squamous cell papilloma |
|
Bone - Jaw - Mandible |
0 - 6.98 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Bone - Jaw - Maxilla dysplasia - epithelial |
|
Bone - Jaw - Maxilla |
0 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Bone - Jaw - Maxilla hyperplasia - basal cell |
|
Bone - Jaw - Maxilla |
0 - 2 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Bone - Jaw - Maxilla hyperplasia - squamous |
|
Bone - Jaw - Maxilla |
0 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Bone - Jaw - Maxilla lesion |
|
Bone - Jaw - Maxilla |
2 - 6 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Bone - Jaw - Maxilla squamous cell carcinoma |
|
Bone - Jaw - Maxilla |
0 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Bone - Jaw - Maxilla squamous cell papilloma |
|
Bone - Jaw - Maxilla |
0 - 2 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Esophagus dysplasia - epithelial | Esophagus |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Esophagus dysplasia - epithelial |
|
Esophagus |
0 - 14 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Esophagus hyperplasia - basal cell | Esophagus |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Esophagus hyperplasia - basal cell |
|
Esophagus |
0 - 30 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Esophagus hyperplasia - squamous | Esophagus |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Esophagus hyperplasia - squamous |
|
Esophagus |
0 - 4 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Esophagus preneoplastic lesion | Esophagus |
0 - observed |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Esophagus squamous cell carcinoma | Esophagus |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Esophagus squamous cell carcinoma |
|
Esophagus |
0 - 14 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Esophagus squamous cell papilloma | Esophagus |
0 - 0.1 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Esophagus squamous cell papilloma |
|
Esophagus |
0 - 2 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Esophagus tumor |
|
Esophagus |
0 - 2 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Forestomach dysplasia - epithelial | Forestomach |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Forestomach dysplasia - epithelial |
|
Forestomach |
0 - 2 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Forestomach hyperplasia - basal cell | Forestomach |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Forestomach hyperplasia - basal cell |
|
Forestomach |
0 - 2 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Forestomach hyperplasia - squamous | Forestomach |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Forestomach hyperplasia - squamous |
|
Forestomach |
0 - 8 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Forestomach preneoplastic lesion | Forestomach |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Forestomach preneoplastic lesion |
|
Forestomach |
0 - 4 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Forestomach squamous cell carcinoma | Forestomach |
0 - 2 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Forestomach squamous cell carcinoma |
|
Forestomach |
0 - 14 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Forestomach squamous cell papilloma | Forestomach |
0 - 0.4 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Forestomach squamous cell papilloma |
|
Forestomach |
0 - 4 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Forestomach tumor - squamous | Forestomach |
0 - 2 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Forestomach tumor - squamous |
|
Forestomach |
0 - 18 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Gingiva dysplasia - epithelial |
|
Gingiva |
0 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Gingiva hyperplasia - basal cell |
|
Gingiva |
2.86 - 9.09 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Gingiva hyperplasia - squamous |
|
Gingiva |
0 - 2.27 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Gingiva squamous cell carcinoma |
|
Gingiva |
0 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Gingiva squamous cell papilloma |
|
Gingiva |
0 - 2.86 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Larynx dysplasia - epithelial | Larynx |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Larynx dysplasia - epithelial |
|
Larynx |
0 - 6 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Larynx hyperplasia - basal cell | Larynx |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Larynx hyperplasia - basal cell |
|
Larynx |
0 - 12 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Larynx hyperplasia - squamous | Larynx |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Larynx hyperplasia - squamous |
|
Larynx |
0 - 2 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Larynx preneoplastic lesion | Larynx |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Larynx preneoplastic lesion |
|
Larynx |
0 - observed |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Larynx squamous cell carcinoma | Larynx |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Larynx squamous cell carcinoma |
|
Larynx |
0 - 4 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Larynx tumor |
|
Larynx |
2 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Nose - Nasal cavity |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma |
|
Nose - Nasal cavity |
0 - 2 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Uterus |
20 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma |
|
Uterus |
16 - 22 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Leukocyte lymphoma | Spleen |
0 - 2 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Leukocyte lymphoma |
|
Spleen |
0 - 10 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Liver hepatocellular adenoma | Liver |
4 - 6 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Liver hepatocellular adenoma |
|
Liver |
0 - 12 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Liver hepatocellular carcinoma | Liver |
2 - 26 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Liver hepatocellular carcinoma |
|
Liver |
0 - 20 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Lung adenoma | Lung |
2 - 6 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Lung adenoma |
|
Lung |
2 - 8 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Lung carcinoma | Lung |
4 - 14 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Lung carcinoma |
|
Lung |
2 - 10 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Mouth - Lip dysplasia - epithelial |
|
Mouth - Lip |
6.82 - 8.57 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Mouth - Lip hyperplasia - basal cell |
|
Mouth - Lip |
9.09 - 22.86 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Mouth - Lip hyperplasia - squamous |
|
Mouth - Lip |
0 - 9.09 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Mouth - Lip squamous cell carcinoma |
|
Mouth - Lip |
2.27 - 5.71 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Mouth - Lip squamous cell papilloma |
|
Mouth - Lip |
0 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Mouth - Oral mucosa dysplasia - epithelial |
|
Mouth - Oral mucosa |
2.04 - 10 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Mouth - Oral mucosa hyperplasia - basal cell |
|
Mouth - Oral mucosa |
2 - 12.24 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Mouth - Oral mucosa hyperplasia - squamous |
|
Mouth - Oral mucosa |
0 - 6 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Mouth - Oral mucosa squamous cell carcinoma |
|
Mouth - Oral mucosa |
0 - 6 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Mouth - Oral mucosa squamous cell papilloma |
|
Mouth - Oral mucosa |
0 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Mouth - Palate dysplasia - epithelial |
|
Mouth - Palate |
0 - 4 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Mouth - Palate hyperplasia - basal cell |
|
Mouth - Palate |
0 - 2.04 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Mouth - Palate hyperplasia - squamous |
|
Mouth - Palate |
0 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Mouth - Palate squamous cell carcinoma |
|
Mouth - Palate |
0 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Mouth - Palate squamous cell papilloma |
|
Mouth - Palate |
0 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Oral cavity dysplasia - epithelial | Oral cavity |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Oral cavity dysplasia - epithelial |
|
Oral cavity |
0 - 48 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Oral cavity hyperplasia - basal cell | Oral cavity |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Oral cavity hyperplasia - basal cell |
|
Oral cavity |
0 - 36 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Oral cavity hyperplasia - squamous | Oral cavity |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Oral cavity hyperplasia - squamous |
|
Oral cavity |
0 - 26 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Oral cavity lesion |
|
Oral cavity |
6 - 10 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Oral cavity preneoplastic lesion | Oral cavity |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Oral cavity preneoplastic lesion |
|
Oral cavity |
0 - observed |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Oral cavity squamous cell carcinoma |
|
Oral cavity |
0 - 30 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Oral cavity squamous cell carcinoma | Oral cavity |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Oral cavity squamous cell papilloma | Oral cavity |
0 - 0.1 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Oral cavity squamous cell papilloma |
|
Oral cavity |
0 - 8 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Oral cavity tumor |
|
Oral cavity |
8 - 12 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Oral cavity tumor - malignant |
|
Oral cavity |
observed |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Oral cavity tumor - squamous | Oral cavity |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Oral cavity tumor - squamous |
|
Oral cavity |
0 - 36 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Stomach tumor |
|
Stomach |
2 - 4 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Tongue squamous cell carcinoma | Tongue |
0 - 4 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Tongue squamous cell carcinoma |
|
Tongue |
0 - 2 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Tongue squamous cell papilloma | Tongue |
0 - 0.1 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Tongue squamous cell papilloma |
|
Tongue |
0 - 2 |
|
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Uterus - Endometrium - Stroma polyp | Uterus - Endometrium - Stroma |
0 |
||
(C57BL/6NCrlj x DBA/2NCrlj)F1 | Uterus - Endometrium - Stroma polyp |
|
Uterus - Endometrium - Stroma |
0 - 2 |